Windward Bio Raises $175M in IPO Priced at $17 a Share
Tom Rudovsky · Reported by Dow Jones Newswires
Sentiment
Neutral
Importance
7
Price
--
Mkt Cap
--
52W Low
--
52W High
--
52W Position
Off High
Rel. Volume
Market data snapshot near publication time
Summary
Windward Bio priced its IPO of 10.3 million shares at $17 apiece, raising roughly $175 million before fees. The deal is a standard-size biotech listing, and the pricing itself is the key data point — no valuation, use of proceeds, or first-day trading level was disclosed in the headline. The stock begins trading on Nasdaq under WWB, and the first session's performance will show whether the $17 clearing price drew real demand.
This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.